Up to 9-day survival and control of thrombocytopenia following alpha1,3-galactosyl transferase knockout swine liver xenotransplantation in baboons

Xenotransplantation

Volumn 19, Issue 4, 2012, Pages 256-264

  Kim, Karen ^a   Schuetz, Christian ^a   Elias, Nahel ^a   Veillette, Gregory R ^a   Wamala, Isaac ^a   Varma, Manish ^a   Smith, R Neal ^a   Robson, Simon C ^b   Cosimi, A Benedict ^a   Sachs, David H ^a   Hertl, Martin ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

baboon; liver; swine; xenotransplantation

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ALPHA 1,3 GALACTOSYLTRANSFERASE; AMINOCAPROIC ACID; ANTIBIOTIC AGENT; ASPARTATE AMINOTRANSFERASE; AZATHIOPRINE; BILIRUBIN; CD40 LIGAND MONOCLONAL ANTIBODY; COBROTOXIN; HUMAN ALBUMIN; IMMUNOGLOBULIN G ANTIBODY; METHYLPREDNISOLONE; TACROLIMUS; THYMOCYTE ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY ANASTOMOSIS; ARTICLE; BABOON; BLEEDING; BLOOD CLOTTING DISORDER; BLOOD CLOTTING PARAMETERS; BLOOD TRANSFUSION; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG EFFICACY; ENTEROCOCCAL INFECTION; ERYTHROCYTE CONCENTRATE; GENE INACTIVATION; GRAFT RECIPIENT; HEART TRANSPLANTATION; HEMATOCRIT; HEPATOJEJUNOSTOMY; HISTOLOGY; HISTOPATHOLOGY; HYPOVOLEMIA; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LABORATORY TEST; LIVER FUNCTION; LIVER FUNCTION TEST; LIVER GRAFT; LIVER GRAFT REJECTION; LIVER RESECTION; LIVER TRANSPLANTATION; MALE; MINIPIG; NONHUMAN; ORGAN DONOR; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SEPSIS; SURGICAL TECHNIQUE; SURVIVAL TIME; THROMBOCYTE COUNT; THROMBOCYTOPENIA; VEIN ANASTOMOSIS; XENOTRANSPLANTATION;

ANIMALS; GALACTOSYLTRANSFERASES; GENE KNOCKOUT TECHNIQUES; GRAFT SURVIVAL; HUMANS; LIVER TRANSPLANTATION; MALE; PAPIO HAMADRYAS; SWINE; SWINE, MINIATURE; THROMBOCYTOPENIA; TIME FACTORS; TRANSPLANTATION, HETEROLOGOUS;

EID: 84865361788     PISSN: 0908665X     EISSN: 13993089     Source Type: Journal    
DOI: 10.1111/j.1399-3089.2012.00717.x     Document Type: Article

References (26)

1. Kolber-Simonds D, Lai L, Watt SR, et al. Production of alpha-1,3-galactosyltransferase null pigs by means of nuclear transfer with fibroblasts bearing loss of heterozygosity mutations. Proc Natl Acad Sci USA 2004; 101: 7335-7340. (Pubitemid 38638033)
2. Kuwaki K, Tseng YL, Dor FJ, et al. Heart transplantation in baboons using alpha1,3-galactosyltransferase gene-knockout pigs as donors: initial experience. Nat Med 2005; 11: 29-31. (Pubitemid 40215833)
3. Yamada K, Yazawa K, Shimizu A, et al. Marked prolongation of porcine renal xenograft survival in baboons through the use of 1,3-galactosyltransferase gene-knockout donors and the cotransplantation of viscularized thymic tissue. Nat Med 2005; 11: 29-34.
4. Powelson J, Cosimi AB, Austen W Jr, et al. Porcine-to-primate orthotopic liver transplantation. Transplant Proc 1994; 26: 1353-1354. (Pubitemid 24211544)
5. Burlak C, Paris LL, Chihara RK, et al. The fate of human platelets perfused through the pig liver: implications for xenotransplantation. Xenotransplantation 2005; 17: 350-361.
6. Calne RY, White HJ, Herbertson BM, et al. Pig-to-baboon liver xenografts. Lancet 1968; 1: 1176-1178.
7. Calne RY, Davis DR, Pena JR, et al. Hepatic allografts and xenografts in primates. Lancet 1970; 1: 103-106.
8. Sachs DH,. Homozygous miniature swine. In:, Swindle MM, Moody DC, Phillips LD, eds. Swine as Models in Biomedical Research. Ames, IA: Iowa State University Press, 1992: 3-15.
9. Sachs DH,. The pig as a xenograft donor. Pathol Biol (Paris) 1994; 42: 217-219.
10. Zhang L, Li Y, Jiang H, Liu J, Zeng Y, Cheng J,. Comparison of hepatic coagulant, fibrinolytic, and anticoagulant functions between banna minipig inbred line and humans. Transplantation 2005; 79: 1128-1131. (Pubitemid 40664009)
11. Tucker A, Belcher C, Moloo B, et al. The production of transgenic pigs for potential use in clinical xenotransplantation: microbiological evaluation. Xenotransplantation 2002; 9: 191-202. (Pubitemid 36358960)
12. Tucker A, Belcher C, Moloo B, et al. The production of transgenic pigs for potential use in clinical xenotransplantation:baseline clinical pathology and organ size studies. Xenotransplantation 2002; 9: 203-208. (Pubitemid 36358961)
13. Ramirez P, Chavez R, Majado M, et al. Life-supporting human complement regulator decay accelerating factor transgenic pig liver xenograft maintains the metabolic function and coagulation in the nonhuman primate for up to 8 days. Transplantation 2000; 70: 989-998.
14. Munitiz V, Ramirez P, Hernandez Q, et al. Hematologic and hepatic function profile comparison between pig and baboon in an orthotopic liver xenotransplantation model. Transplant Proc 1999; 31: 2641-2642. (Pubitemid 29434088)
15. Ramirez P, Yelamos J, Parrilla P, Chavez R,. Hepatic xenotransplantation will benefit from strategies aimed to reduce complement activation. Liver Transpl 2001; 7: 562-563. (Pubitemid 32549725)
16. Ekser B, Long C, Echeverri GJ, et al. Impact of thrombocytopenia on survival of baboons with genetically modified pig liver transplants: clinical relevance. Am J Transplant 2010; 10: 273-285.
17. Ekser B, Echeverri GJ, Hassett AC, et al. Hepatic function after genetically engineered pig liver transplantation in baboons. Transplantation 2010; 90: 483-493.
18. Tseng YL, Moran K, Dor FJ, et al. Elicited antibodies in baboons exposed to tissues from alfa 1,3-galactosyltransferase gene-knockout pigs. Transplantation 2006; 81: 1058-1062. (Pubitemid 43670441)
19. Shimizu A, Hisashi Y, Kuwaki K, et al. Thrombotic microangiopathy associated with humoral rejection of cardiac xenografts from 1,3-galactosyltransferase gene-knockout pigs in baboons. Am J Pathol 2008; 172: 1471-1481. (Pubitemid 351793341)
20. Hisashi Y, Yamada K, Kuwaki K, et al. Rejection of cardiac xenografts transplantation from alfa 1,3-galactosyltransferase gene-knockout (GalT-KO) pigs to baboons. Am J Transplant 2008; 8: 2516-2526.
21. Rees MA, Butler AJ, Davies HFS, et al. Porcine livers perfused with human blood mount a graft-versus-"host" reaction. Transplantation 2002; 73: 1460-1467. (Pubitemid 34547468)
22. Rees MA, Butler AJ, Chavez-Cartaya G, et al. Prolonged function of extracorporeal hDAF transgenic pig livers perfused with human blood. Transplantation 2002; 73: 1194-1202. (Pubitemid 34454263)
23. Rees MA, Butler AJ, Negus MC, Davies HFS, Friend PJ,. Classical pathway complement destruction is not responsible for the loss of human erythrocytes during porcine liver perfusion. Transplantation 2004; 77: 1416-1423. (Pubitemid 38668438)
24. Satoh T, Aramini JM, Li S, et al. Bioactive peptide design based on protein surface epitopes. A cyclic heptapeptide mimics CD4 domain 1 CC' loop and inhibits CD4 biological function. J Biol Chem 1997; 272: 12175-12180. (Pubitemid 27202801)
25. Ide K, Ohdan H, Kobayashi T, Hara H, Ishiyama K, Asahara T,. Antibody- and complement-independent phagocytotic and cytolytic activities of human macrophages toward porcine cells. Xenotransplantation 2005; 12: 181-188. (Pubitemid 40524978)
26. Koster A, Schirmer U,. Re-evaluation of the role of antifibrinolytic therapy with lysine analogs during cardiac surgery in the post aprotinin era. Curr Opin Anaesthesiol 2011; 24: 92-97.